THOMAS X. NEENAN

Profile

First Name

: THOMAS

Middle Name

: X.

Last Name

: NEENAN

Related Companies

Titles

Company Name

Related People

DIRECTOR, EXECUTIVE OFFICER

SUN BIOPHARMA, INC.

MICHAEL T. CULLEN, SUZANNE GAGNON, RYAN R. GILBERTSON, JEFFREY R. HARDER, PAUL M. HERRON, CHRISTOPHER R. JOHNSON, RANDALL L. JOHNSON, DAVID B. KAYSEN, CLIFFORD F. MCCURDY, III, DOUGLAS M. POLINSKY, DANIEL E. RYWECK, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, DONALD R. SCHEMEL

DIRECTOR, EXECUTIVE OFFICER

SUN BIOPHARMA RESEARCH, INC.

MICHAEL T. CULLEN, SUZANNE GAGNON, RYAN R. GILBERTSON, JEFFREY R. HARDER, PAUL M. HERRON, CHRISTOPHER R. JOHNSON, RANDALL L. JOHNSON, DAVID B. KAYSEN, CLIFFORD F. MCCURDY, III, DOUGLAS M. POLINSKY, DANIEL E. RYWECK, PAUL W. SCHAFFER, D. ROBERT SCHEMEL, DONALD R. SCHEMEL

EXECUTIVE OFFICER, DIRECTOR

ABFERO PHARMACEUTICALS, INC.

STEVEN BURKE, THOMAS X NEENAN, MICHAEL PENINGTON

EXECUTIVE OFFICER

SEAN KEVLAHAN, SHASHI MURTHY

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-05-05

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-06-12

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2019-02-20

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2019-02-20

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2015-09-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2014-01-24

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2013-05-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2013-05-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2012-02-25